Log in
Sign up
Exscientia

Exscientia

Exscientia is a Dundee-based biotechnology company that was founded in 2012.

OverviewStructured DataIssuesContributorsActivity
Contents

Exscientia is a pharmaceutical technology company that automates drug design. The company is a drug discovery company that generates data before through the analytical power of artificial intelligence.

Exscientia has developed algorithms that have reduced the time for drug discovery and development by 70%. With their help, it was possible to create drugs for the treatment of oncological, immune and psychiatric diseases.

Now there are more than 25 drugs in the development of Exscientia. The most successful have gone from identifying a drug target to choosing a candidate for a drug in less than 1.5 years. When using conventional technologies, this process takes 4.5 years.

In September 2021, Exscientia received a $35 million investment from the Bill and Melinda Gates Foundation to develop a drug against COVID-19, influenza and other viruses that could cause a new pandemic.

Timeline

No Timeline data yet.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

https://investors.exscientia.ai/press-releases/press-release-details/2021/Exscientia-acquires-personalised-medicine-AI-pioneer-A

References

exscientia.ai
exscientia.co.uk
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Drug discovery
Drug discovery
Pharmaceutical industry
Pharmaceutical industry
Healthcare
Healthcare
Biomedical engineering
Biomedical engineering
Technology
Technology
Biotechnology
Biotechnology
...
Location
Miami
Miami
-1
United Kingdom
United Kingdom
Oxford
Oxford
-1
Dundee
Dundee
-1
Osaka
Osaka
-1
Vienna
Vienna
-1
B2X
B2B
B2B
CEO
Andrew Hopkins
Andrew Hopkins
-1
Founder
Andrew Hopkins
Andrew Hopkins
-1
AngelList URL
angel.co/exscientia
Pitchbook URL
pitchbook.com/profiles...168229-09
Legal Name
Exscientia plc-1
Date Incorporated
2012
Number of Employees (Ranges)
51 – 200
Full Address
Exscientia Inc, Office 400E, 2125 Biscayne Blvd, Miami, FL 33137. USA-1
Dundee One, RiverCourt, 5 West Victoria Dock Road, Dundee, DD1 3JT-1
The Schrödinger Building Oxford Science Park Oxford OX4 4GE England, United Kingdom-1
Campus-Vienna-Biocenter 5, A-1030 Vienna, Austria-1
2-2-2 Umeda, Kita, Osaka-shi, Osaka, 530-0001-1
CIK Number
1,865,408-1
Place of Incorporation
United Kingdom
United Kingdom
-1
Investors
Pivotal bioVenture Partners
Pivotal bioVenture Partners
Sanofi
Sanofi
Celgene
Celgene
Farallon Capital Management
Farallon Capital Management
Casdin Capital
Casdin Capital
Bristol-Myers Squibb
Bristol-Myers Squibb
BlackRock Innovation Capital
BlackRock Innovation Capital
‌
Laurion Capital
...
Founded Date
2012
Email Address
investors@exscientia.ai-1
careers@exscientia.ai-1
contact@exscientia.co.uk
partnerships@exscientia.ai-1
media@exscientia.ai-1
info@exscientia.ai-1
Phone Number
+441865818941-1
Total Funding Amount (USD)
733,200,000
Latest Funding Round Date
April 27, 2021
Stock Symbol
EXAI-1
Exchange
Nasdaq
Nasdaq
-1
Board of Directors
‌
Robert Ghenchev
-1
Ben Taylor
Ben Taylor
-1
‌
David Nicholson (entrepreneur)
-1
‌
Mario Polywka
-1
Elizabeth Crain
Elizabeth Crain
-1
Andrew Hopkins
Andrew Hopkins
-1
CTO
Garry Pairaudeau
Garry Pairaudeau
-1
CFO
Ben Taylor
Ben Taylor
-1
Latest Funding Type
Private equity
Private equity
Wellfound ID
exscientia
Country
United Kingdom
United Kingdom
-1

Other attributes

Company Operating Status
Active-1
Latest Funding Round Amount (USD)
525,000,000
Previous Name
Exscientia Ltd-1
SIC Code
2,836-1

Find more companies like Exscientia

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.